N/A
N=104
Shifting Rehabilitation Paradigms in Skilled Nursing Facilities
Physical Deconditioning
Bottom Line
View on ClinicalTrials.gov: NCT02927171 ↗Enrolled (actual)
104
Serious AEs
0.0%
Results posted
Apr 2020
Primary outcome: Primary: Short Physical Performance Battery (SPPB) — 3.6; 4.3 score on a scale — p=0.17
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- IntenSive Therapeutic Rehabilitation for Older Skilled Nursing Home Residents (Other)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- VA Office of Research and Development
- Primary completion
- Oct 2018
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Short Physical Performance Battery (SPPB) |
3.6; 4.3 | 0.17 |
| SECONDARY Gait Speed |
0.3; 0.5 | — |
Summary
This study seeks to improve rehabilitation methods for restoring physical function with skilled nursing facility care. More specifically, this study is designed to evaluate the effectiveness of an intensive therapeutic rehabilitation program for older adult skilled nursing home residents compared to usual care.
Eligibility Criteria
Inclusion Criteria
- Adults > 18 years of age who are admitted to a skilled nursing facility following hospitalization
- Qualify to receive at least physical therapy services
Exclusion Criteria
- Patients with primary diagnoses related to neurological disorders will be excluded as patient needs require more of a motor control approach rather than the proposed high-intensity approach. Such patient populations include:
- Parkinson's Disease
- Traumatic Brain Injury
- Recent Cerebral Vascular Accident
- Alzheimer's Disease
- Patients on hospice care will be excluded as the approach is based on palliative principles.
- Other patients to be excluded will include those with conditions where strength training is contraindicated (as indicated by the American College of
Sports Medicine Guidelines for Exercise Testing and Prescription):
- Recent unstable fracture
- Advanced congestive heart failure
- Bone metastasis sites
- Tumors in strengthening target areas
- Acute Illness
- Recent myocardial infarction (within 3-6 weeks)
- Weight bearing restrictions on graft or fracture sites
- Exposed tendon or muscle
- Absence of pedal pulses
- Presence of fistula
- Platelet levels <50,000/ L
Data sourced from ClinicalTrials.gov (NCT02927171). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.